Use of medicament of geldanamycin derivative for preparing medicament for curing chemotherapy induction alopecia

A technology of geldanamycin and methoxygeldanamycin, which is applied in the field of geldanamycin derivatives, can solve problems such as unisolated geldanamycin-resistant strains, and achieve reliable and safe sex, reduce psychological stress, and improve the quality of life

Inactive Publication Date: 2008-09-03
2 Cites 1 Cited by

AI-Extracted Technical Summary

Problems solved by technology

After 41 passages in vitro, no geldanamyc...
View more


The invention relates to the new use of geldanamycin derivative, particularly to an application of the geldanamycin derivative in preparing drugs for treating chemotherapy-induced alopecia. The invention provides an application of geldanamycin derivative 17-allylaniino-17-demethoxy-geldanamycin (17-AAG) in preparing drugs for treating chemotherapy-induced alopecia. The inventive geldanamycin derivative 17-AAG can be used for developing new drugs for treating chemotherapy-induced alopecia, which have reliable safety and can remarkably improve the life quality of chemotherapy patients and relieve mental pressure of patients, so as to better cooperate with cancer treatment.

Application Domain

Organic active ingredientsDermatological disorder +1

Technology Topic

DrugChemotherapy induced alopecia +4


  • Use of medicament of geldanamycin derivative for preparing medicament for curing chemotherapy induction alopecia
  • Use of medicament of geldanamycin derivative for preparing medicament for curing chemotherapy induction alopecia
  • Use of medicament of geldanamycin derivative for preparing medicament for curing chemotherapy induction alopecia


  • Experimental program(1)

Example Embodiment

[0030] Example: Animal model and treatment of hair loss after chemotherapy
[0031] 1. Experimental materials
[0032] The experimental animals were SPF Km mice aged 4-6 weeks, provided by the Experimental Animal Center of Sun Yat-Sen University, and raised at room temperature.
[0033] Cyclophosphamide and paclitaxel for injection were purchased from Sun Yat-sen University Cancer Hospital, and other commercially available products can also be used;
[0034] Therapeutic drugs: 17-propenylamino-17-demethoxygeldanamycin (17-AAG), purchased from SIGMA.
[0035] Others: physiological saline; chloral hydrate; heating equipment such as water bath.
[0036] 2. Experimental methods and results
[0037] The experimental mice were randomly divided into five groups: control group, cyclophosphamide chemotherapy experimental group (no drug treatment), cyclophosphamide chemotherapy + drug treatment group, paclitaxel chemotherapy group (no drug treatment), paclitaxel chemotherapy + drug treatment group.
[0038] Cut off the back hairs of the mice in each of the above groups, and after the new hairs grow out, inject cyclophosphamide 120mg/kg body weight and paclitaxel 50mg/kg body weight into the abdominal cavity to induce hair loss (except the control group), and inject it every seven days One time, three consecutive injections.
[0039] Results: Compared with the control group, the mice in the cyclophosphamide and paclitaxel chemotherapy group showed obvious hair loss. Such as figure 1 Shown.
[0040] The mice were treated after the third injection. Cut off all the remaining hairs on the back of the mouse, and inject 0.05ml of 50μM drug (geldanamycin 17-AAG) intracutaneously into the back. The treatment area is about 7-8cm. 2. Histochemical HE staining was used to detect hair follicle changes.
[0041] Result: After a week, new hairs grew on the back and around the area where Geldanamycin 17-AAG was injected, while the other parts were not long and formed round spots. The effect was obvious. figure 2 Shown.
[0042] The weight change of the drug before and after administration can be used to analyze the toxic and side effects of the drug on mice. After testing, the average weight data of each group of mice is shown in Table 1 and image 3 Shown:
[0043] Table 1: Changes in body weight of mice in each group before and after treatment
[0044] Normal control mice
[0045] Conclusion: The drug has no obvious side effects on mice.
[0046] The mice in each group were put to death by pulling their tails and necks severed. The skin tissues of the back were stained with histochemical HE staining method to observe the changes of hair follicles. Such as image 3 As shown, a is the normal control group, and the number of hair follicles is normal; b is the treatment group after paclitaxel chemotherapy, and the number of hair follicles is the same as the normal group; c is the treatment after cyclophosphamide chemotherapy, and the number of hair follicles is the same as the normal group; d is the non-treatment group of cyclophosphamide chemotherapy, with fewer hair follicles; e is the non-treatment group of paclitaxel chemotherapy, with fewer hair follicles.


no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Protection module for control and protective switching device

ActiveUS20150138685A1high reliabilitysafe and reliable

A kind of decellularized anti-calcification heart patch and preparation method thereof

ActiveCN104998299Bsafe and reliableSignificant anti-calcification ability

Door peep glass with view screen

InactiveCN106703659Asafe and reliable

Control unit and method for controlling a radiation therapy system, and radiation therapy system

InactiveUS20080304623A1safe and reliablefew side effect

Classification and recommendation of technical efficacy words

  • safe and reliable
  • improve the quality of life

Tool belt with integrated tool retraction mechanism

InactiveUS20130008933A1easily and comfortably access and utilizedsafe and reliable

Food safety and risk analyzer

InactiveUS20130089838A1readily adaptsafe and reliable

Distributed information recording system and method based on Internet of Things and block chain

InactiveCN109413133ASafe and reliableSafeguard data

Connectors for fluid containers

ActiveUS20130218120A1safe and reliable

Culture healthy pig feed containing chlorella vulgaris and preparation method thereof

InactiveCN107080045Abalanced nutritionsafe and reliable

Method for improving production performance of laying hens

InactiveCN105379668APromote industrial progress and developmentimprove the quality of life
Owner:广东省家禽科学研究所 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products